Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy.
Transl Lung Cancer Res
; 9(5): 2059-2073, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-33209626
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Transl Lung Cancer Res
Year:
2020
Document type:
Article
Affiliation country:
China
Country of publication:
China